Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Inter grader agreement in the Danish screening program for diabetic retinopathy

Anne Suhr Thykjær; Lonny Stokholm; Ryo Kawasaki; Kurt Højlund; Katrine Hass Rubin; Katja Schielke; Caroline Laugesen; Nis Andersen; Jens Andresen; Steffen Heegaard; Jakob Grauslund

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):567 – A0132.

ARVO Annual Meeting Abstract June 2020

Non-attendance at diabetic eye screening in a national screening program: data from 206,220 patients

Anne Suhr Thykjær; Lonny Merete Stokholm; Kurt Højlund; Katrine Hass Rubin; Ryo Kawasaki; Jakob Grauslund

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3820.

ARVO Annual Meeting Abstract June 2020

Associations between retinal artery occlusions and cardiovascular disorders: a nationwide, registry-based, case-control study.

Jakob Grauslund; Lonny Merete Stokholm; Katrine Hartmund Frederiksen; Peter Hartmund Frederiksen; Gerda Møller; Kirsten Kyvik; Morten de la Cour; Line Kessel; Katrine Hass Rubin; Christina Jørgensen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3852.

ARVO Annual Meeting Abstract June 2020

Associations between retinal vein occlusions and cardiovascular disorders: a prospective nationwide registry-based case-control study

Lonny Stokholm; Katrine Hartmund Frederiksen; Christina Jørgensen; Peter Hartmund Frederiksen; Tunde Peto; Ryo Kawasaki; Kirsten Kyvik; Morten de la Cour; Line Kessel; Katrine Hass Rubin; Jakob Grauslund

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3854.

ARVO Annual Meeting Abstract July 2019

AAVHSCs target multiple cell types in the eye and have potential to treat rare retinal diseases

Sumeet Sarin; Nancy Avila; Laura Smith; Hillard Rubin; Pablo Morales; Jeff L. Ellsworth; Jacinthe Gingras; Omar Francone; Albert Seymour

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2914.

ARVO Annual Meeting Abstract June 2015

Role of Myocilin Mutants and Wnt Signaling in Glaucoma

Peter Pechan; Jeffery Ardinger; Hillard Rubin; Michael Lukason; Elizabeth Barry; Seng Cheng; Abraham Scaria

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1973.

ARVO Annual Meeting Abstract May 2008

Minimal Effective Dosing of a Novel Recombinant Form of VEGF Soluble Receptor 1 (sFlt-1) Delivered via AAV Vector in Inhibiting Choroidal Neovascularization in a Murine Model

W. W. Hauswirth; R. Miller; J. Pang; V. Choido; A. Abraham; P. Pechan; H. Rubin; S. Wadsworth; Q. Li

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1375.

ARVO Annual Meeting Abstract May 2006

Novel Anti–VEGF Molecules for Inhibition of Angiogenesis in the Eye

P. Pechan; H. Rubin; M. Lukason; J. Ardinger; D. Woodcock; J. Jaworski; H. Qiu; W. Hauswirth; S. Wadsworth; A. Scaria

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):854.

ARVO Annual Meeting Abstract May 2006

A Novel Recombinant Form of VEGF Soluble Receptor 1 (sFlt–1) Delivered via AAV Vectors Effectively Inhibits Choroidal Neovascularization in a Murine Model

Q. Li; R. Miller; J. Pang; S. Boye; V. Choido; A. Scaria; P. Pechan; H. Rubin; S. Wadsworth; W. Hauswirth

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):901.

ARVO Annual Meeting Abstract May 2004

Intraocular Gene Delivery of Soluble VEGF Receptors

P. Pechan; M. Lukason; H.L. Rubin; A. Scaria; S. Wadsworth

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3712.

Advertisement